VA launches trial of GLP-1 drugs to treat alcohol use disorder in veterans

The VA is launching a new clinical trial to test whether blockbuster GLP-1 drugs used for weight loss and type 2 diabetes can treat alcohol use disorder in veterans.

Here's how much retiring in 2026 could cost you in health care expenses

A new Fidelity Investments analysis finds that health care costs for Americans retiring in 2026 are expected to rise 7.5% from last year.

Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads

Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly’s Mounjaro and Zepbound outperform Novo’s Ozempic and Wegovy. 

Former NFL star Chris Johnson reveals ALS battle
video

Former NFL star Chris Johnson, 40, recently announced he was diagnosed with ALS. Johnson ran for 2,000 yards in his second season with the Tennessee Titans in 2009 on his way to three consecutive Pro Bowl appearances. He was also named the 2009 Offensive Player of the Year. LiveNOW’s Anna Marsick is speaking with Dr. Imad Najm, a Cleveland Clinic Neurologist, to learn more about Johnson’s battle and the rise in neurological diseases that are impacting aging populations. 

Arizona toddler found alive in hospital morgue after being declared dead

An 18-month-old Gilbert boy was found breathing in a hospital morgue nearly five hours after being declared dead following a pool incident.

Obamacare premiums going up next year - Here's why

Millions of Americans who buy health insurance through the Affordable Care Act marketplace could face another year of higher premiums in 2027.

Medicare rolls out $50 GLP-1 drug program: What to know

GLP-1 weight loss drugs will be a lot cheaper for many older Americans with the rollout of Medicare’s $50-a-month GLP-1 program.  

CVS Caremark to cover Zepbound again after lawsuit, widespread backlash

CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.

Vanessa Trump reveals breast cancer diagnosis

Vanessa Trump revealed Wednesday that she has been diagnosed with breast cancer and has started a treatment plan.

WHO declares Ebola health emergency in Central Africa
video

We are learning more this weekend about what experts are describing as an Ebola outbreak in Central Africa. The World Health Organization declared the outbreak an international public health emergency on Sunday. This came after dozens of suspected deaths were reported in the Democratic Republic of Congo and neighboring Uganda. LiveNOW’s Andy Mac is learning more about the response to the outbreak with Dr. Amesh Adalja who works as a Senior Scholar at the Johns Hopkins University Center for Health Security. 

California’s $1.3B Medicaid funding put on hold amid fraud suspicions

The Trump administration is widening its initiative to eliminate fraud in the federal health program, which includes a $1.3 billion deferral of Medicaid funding to California.

Two passengers of hantavirus-hit cruise arrive in GA
video

We are listening in to a news conference this Monday as passengers from the M/V Hondius cruise ship are continuing to make their way home following a deadly hantavirus outbreak tied to the vessel. According to our partners at FOX 5 Atlanta, the Georgia Department of Public Health previously confirmed that two residents from the state who were aboard the cruise ship have already returned for treatment. Officials from Emory University Hospital gave an update on Monday. 

Supreme Court restores abortion pill access
video

LiveNOW’s Shawna Khalafi is speaking with Pam Belluck, a health and science reporter for The New York Times, as the Supreme Court restored broad access to the abortion pill mifepristone last week. This came after a federal appeals court ruled mifepristone must be dispensed in person. The move essentially blocked mail delivery of the pill. The legal fight centered around a lawsuit from Louisiana, where officials argued that the drug's availability conflicted with the state's existing ban.